Latest news
Loading news…
SinoTau is a total solution provider specializing in generic drugs and innovative drugs.
SinoTau was acquired by Tus-Guhan Group in 2022.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Beijing, China
1
professional contacts at SinoTau
Contact execs at SinoTau →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to SinoTau
Loading news…
FAQs about SinoTau
People who checked this page also checked these
Browse the full Acquirezy directory.